Bryn Mawr Capital Management LLC Buys 4,876 Shares of Colgate-Palmolive (NYSE:CL)

Bryn Mawr Capital Management LLC raised its stake in Colgate-Palmolive (NYSE:CL) by 126.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,739 shares of the company’s stock after purchasing an additional 4,876 shares during the quarter. Bryn Mawr Capital Management LLC’s holdings in Colgate-Palmolive were worth $697,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. OFI Invest Asset Management bought a new stake in Colgate-Palmolive in the 3rd quarter valued at $25,000. Avion Wealth boosted its stake in Colgate-Palmolive by 78.1% in the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after purchasing an additional 175 shares during the period. McGlone Suttner Wealth Management Inc. acquired a new position in Colgate-Palmolive in the 4th quarter valued at $34,000. Kayne Anderson Rudnick Investment Management LLC raised its holdings in Colgate-Palmolive by 142.0% in the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after acquiring an additional 291 shares in the last quarter. Finally, West Branch Capital LLC raised its holdings in Colgate-Palmolive by 24.0% in the 4th quarter. West Branch Capital LLC now owns 682 shares of the company’s stock valued at $54,000 after acquiring an additional 132 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on CL. JPMorgan Chase & Co. lifted their price objective on Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a report on Thursday, January 18th. Morgan Stanley upped their target price on Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a report on Monday, January 29th. Stifel Nicolaus upped their target price on Colgate-Palmolive from $89.00 to $94.00 and gave the stock a “buy” rating in a report on Wednesday, April 10th. Raymond James raised Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 target price for the company in a report on Monday, January 29th. Finally, Citigroup upped their target price on Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, April 16th. Three analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and a consensus price target of $89.50.

Insider Buying and Selling

In related news, insider Jennifer Daniels sold 3,538 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total transaction of $299,562.46. Following the transaction, the insider now directly owns 59,698 shares of the company’s stock, valued at approximately $5,054,629.66. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, EVP Gregory Malcolm sold 8,930 shares of the stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $85.35, for a total value of $762,175.50. Following the completion of the sale, the executive vice president now directly owns 8,043 shares of the company’s stock, valued at $686,470.05. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Jennifer Daniels sold 3,538 shares of the stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total value of $299,562.46. Following the completion of the sale, the insider now directly owns 59,698 shares of the company’s stock, valued at $5,054,629.66. The disclosure for this sale can be found here. In the last three months, insiders have sold 232,371 shares of company stock valued at $19,505,099. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Stock Up 1.9 %

Shares of Colgate-Palmolive stock opened at $90.99 on Friday. Colgate-Palmolive has a one year low of $67.62 and a one year high of $92.25. The company has a debt-to-equity ratio of 8.59, a current ratio of 1.11 and a quick ratio of 0.71. The stock’s 50-day moving average is $87.66 and its 200 day moving average is $81.46. The firm has a market cap of $74.79 billion, a price-to-earnings ratio of 32.73, a PEG ratio of 3.35 and a beta of 0.42.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, beating the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The company had revenue of $5.07 billion for the quarter, compared to analyst estimates of $4.96 billion. During the same quarter in the prior year, the company earned $0.73 EPS. The firm’s revenue for the quarter was up 6.2% compared to the same quarter last year. Equities research analysts anticipate that Colgate-Palmolive will post 3.5 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be paid a dividend of $0.50 per share. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 dividend on an annualized basis and a yield of 2.20%. The ex-dividend date is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio is 71.94%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.